** Shares of medical device maker Edwards Lifesciences EW.N rise 4.3% to $73.50 premarket
** Company late on Wednesday raised its 2025 sales forecast to a range of $5.7 billion to $6.1 billion, from between $5.6 billion and $6 billion earlier
** Edwards expects a tariff impact of 5 cents per share for 2025, with a larger hit expected in 2026
** Company posted Q1 adj. profit of 64 cents per share, beating analysts' estimates of 60 cents per share, according to data compiled by LSEG
** Co also reaffirmed its 2025 adjusted profit of $2.40 to $2.50 per share
** As of last close, EW has fallen 4.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。